×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
e-therapeutics (LON:ETX) Stock Passes Below 200 Day Moving Average of $11.62
Defense World
Read e-therapeutics (LON:ETX) Stock Passes Below 200 Day Moving Average of $11.62 at Defense World.
1 day ago
We're Hopeful That e-therapeutics (LON:ETX) Will Use Its Cash Wisely
Yahoo Finance
Since its cash burn is increasing (albeit only slightly), e-therapeutics shareholders should still be mindful of the possibility it will require...
4 months ago
E-Therapeutics Shifts from AIM to JP Jenkins Platform - TipRanks.com
Tipranks
E Therapeutics (GB:ETX) has released an update. E-Therapeutics plc, known for its RNAi medicine discovery platform, announces today as the last trading day...
2 weeks ago
e-Therapeutics proposes £29m fundraising, delisting from AIM
Sharecast.com
RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.
1 month ago
Big firms quitting UK 'not a crisis' says stock market boss
BBC
Many big firms are delisting in the UK but the London Stock Exchange's chief says there is no need to panic.
1 week ago
Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors - boerse.de
boerse.de
23rd May 2024. JPJ:ETX. ISIN: GB00B2823H99. e-therapeutics plc. ("e-therapeutics" or “ETX” or the "Company"). Lord David Prior Appointed as...
3 days ago
e-Therapeutics starts last day of AIM market listing
Proactive financial news
e-Therapeutics PLC (AIM:ETX, OTCQX:ETXPF) reminded investors today will be the last day its ordinary shares will be listed on the AIM market...
2 weeks ago
e-therapeutics is latest UK biotech to seek AIM de-listing
Pharmaphorum
e-therapeutics is the latest UK biotech to say it plans to delist from the AIM, citing a lack of interest from institutional investors.
1 month ago
UK Biotech Co. Seeks To Raise £29M, Delist Shares From AIM
Law360
U.K. biotechnology group e-Therapeutics PLC said on Wednesday that it has agreed to raise £28.9 million ($36.7 million) and leave the London...
1 month ago
Lyndra Therapeutics Raises $101 Million in Series E Funding
Business Wire
Lyndra Therapeutics closed a $101 million Series E financing round led by Sarissa Capital and including Sun Pharma and Polaris Partners.
5 months ago